Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia’s CGPP Programme
-
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
-
Powell Max Limited Successfully Repositions for Its Next Phase of Growth
-
Prairie Operating Co. Announces Participation in Upcoming Conference
-
OZOP Energy Solutions, Inc. Highlights NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink
-
GlobalFoundries Announces Availability of AutoPro150 eMRAM Technology on Enhanced FDX Platform for Advanced Automotive Applications
-
First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics
-
SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
-
Alico to Participate at 38th Annual Roth Conference
-
Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11
-
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
-
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
-
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
-
Syntec Optics (Nasdaq: OPTX) Secures $4M in Defense Orders Across Diversified U.S. Military Platforms
-
Jeffs' Brands: KeepZone AI Enters into Channel Partner Agreement for 4G/5G Infrastructure
-
Jeffs' Brands: KeepZone AI Enters into Channel Partner Agreement for 4G/5G Infrastructure
-
Safe Harbor Financial CEO Highlights Growth Platform Launch, Debt Elimination, and Financial Stabilization in Letter to Shareholders
-
BW Offshore: New awards under Long-Term Incentive Programme
-
Adeia Enters into Multi-Year IP License Agreement with AMD
-
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
-
Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology
-
AVAX One To Participate in the Digital Chamber’s DC Blockchain Summit 2026
-
Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annu
-
CORRECTION – La Mancha Exercises Right to Subscribe for Additional Shares of G Mining Ventures
-
Brighty Launches Banking AI Agents for Corporate Clients
-
Entente Foundation announces Dr. Jennifer Watt as new chair in geriatric medicine
-
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
-
CPI Aerostructures Receives Funded Orders from Sikorsky to Support MH-60 SEAHAWK Helicopter Sustainment
-
Meyer Wilson Werning Secures $2.3 Million Arbitration Award for Eleven Families in Investment Advisory Breach of Fiduciary Duty Case
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director and Provides Patent Portfolio Update for Texatron Fusion Platform
-
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026
-
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
-
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
-
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
-
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
-
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
-
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
-
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
-
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
-
Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops
-
Hyperion DeFi Announces Private Lending Pool Built by HyperLend
-
Sharplink Reports Full Year 2025 Financial and Operating Results
-
Route 92 Medical Enrolls First Patient in SUMMIT RISE Study
-
Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
-
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
-
Kandal M Venture Limited Announces Investment in Manufacturing Facility in the Philippines to Diversify Global Footprint
-
eToro Group Reports Selected February Business Metrics
-
Controlled Thermal Resources and Plum Acquisition Corp. IV Announce Definitive Business Combination Agreement to Advance U.S. Critical Minerals and Energy
-
New American Drone and Defense Company to be Created Through Merger of Powerus and Aureus Greenway Holdings
-
Byrna Technologies Announces Preliminary Fiscal First Quarter Revenues of $29.0 Million
